Published in Neurology on December 01, 1982
Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol (2008) 2.93
Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr (2007) 2.47
Virtual-pinhole PET. J Nucl Med (2008) 2.37
A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J (2012) 1.82
In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis. Int J Cardiovasc Imaging (2008) 1.52
Brain tumors. West J Med (1991) 1.44
Molecular imaging of gliomas with PET: opportunities and limitations. Neuro Oncol (2011) 1.40
Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol (2009) 1.30
[18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors. Eur J Nucl Med Mol Imaging (2005) 1.27
Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine. Eur J Nucl Med Mol Imaging (2003) 1.23
Imaging in neurooncology. NeuroRx (2005) 1.14
Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium. J Nucl Med (2011) 1.14
The use of PET in evaluating patients with primary brain tumours: is it useful? J Neurol Neurosurg Psychiatry (1995) 1.12
Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism. Cancer Metab (2013) 1.12
Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer. Breast Cancer Res (2003) 1.10
PET scanning. BMJ (1989) 1.08
Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment's roles together with hexokinase-2 in the "Warburg effect" in cancer. J Bioenerg Biomembr (2008) 1.07
Brain tumors. Semin Nucl Med (2012) 1.05
Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors. Mol Imaging (2014) 1.04
Imaging the head: functional imaging. J Neurol Neurosurg Psychiatry (1995) 0.99
Diagnostic value of kinetic analysis using dynamic FDG PET in immunocompetent patients with primary CNS lymphoma. Eur J Nucl Med Mol Imaging (2006) 0.98
Intraoperative infrared imaging of brain tumors. J Neurosurg (2004) 0.98
Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro Oncol (2005) 0.97
Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature. Radiat Oncol (2013) 0.97
18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome. J Cancer Res Clin Oncol (2007) 0.97
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response. Front Neurol (2015) 0.97
FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan. Neuro Oncol (2012) 0.94
¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas. Eur J Nucl Med Mol Imaging (2012) 0.92
Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism. Am J Hum Genet (2011) 0.91
Regulation of cell proliferation and migration in glioblastoma: new therapeutic approach. Front Oncol (2013) 0.89
The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer. Mol Clin Oncol (2015) 0.86
The new FDG brain revolution: the neurovascular unit and the default network. Eur J Nucl Med Mol Imaging (2010) 0.86
Emerging techniques and technologies in brain tumor imaging. Neuro Oncol (2014) 0.86
Is there still a role for SPECT-CT in oncology in the PET-CT era? Nat Rev Clin Oncol (2012) 0.86
The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann Surg (1992) 0.86
Applications of positron emission tomography (PET) in neurology. J Neurol Neurosurg Psychiatry (2004) 0.86
Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC). Eur J Nucl Med Mol Imaging (2008) 0.85
[11C]-Methionine PET: dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms. J Neurol Neurosurg Psychiatry (2005) 0.85
Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat. Eur J Nucl Med Mol Imaging (2006) 0.84
Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. J Nucl Cardiol (2012) 0.84
Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma. EMBO J (2015) 0.82
Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography. Neuroradiology (2003) 0.82
PET imaging in pediatric neuroradiology: current and future applications. Pediatr Radiol (2009) 0.82
F-18 FDG PET-CT for predicting survival in patients with recurrent glioma: a prospective study. Neuroradiology (2011) 0.82
Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium. J Nucl Med (2013) 0.81
Imaging biomarkers in primary brain tumours. Eur J Nucl Med Mol Imaging (2014) 0.80
Glucose corrected standardized uptake value (SUVgluc) in the evaluation of brain lesions with 18F-FDG PET. Eur J Nucl Med Mol Imaging (2013) 0.78
In vivo measurement of regional brain and tumor pH using [14C]dimethyloxazolidinedione and quantitative autoradiography. II: Characterization of the extracellular fluid compartment using pH-sensitive microelectrodes and [14C]sucrose. J Cereb Blood Flow Metab (1986) 0.78
18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer. Thorax (2001) 0.78
Evaluation of the diagnostic performance of magnetic resonance spectroscopy in brain tumors: a systematic review and meta-analysis. PLoS One (2014) 0.78
Glucose metabolism in gastric cancer: The cutting-edge. World J Gastroenterol (2016) 0.78
Imaging tumor metabolism using positron emission tomography. Cancer J (2015) 0.78
D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects. J Bioenerg Biomembr (2012) 0.78
Correlation of (18)F-FDG PET and MR Apparent Diffusion Coefficient (ADC) Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium. J Nucl Med (2017) 0.77
Metformin and cancer: Technical and clinical implications for FDG-PET imaging. World J Radiol (2015) 0.76
FDG-PET imaging to detect and characterize infectious disorders; an unavoidable path for the foreseeable future. Eur J Nucl Med Mol Imaging (2017) 0.75
History and future technical innovation in positron emission tomography. J Med Imaging (Bellingham) (2017) 0.75
Role of (18)F-fluorodeoxyglucose Positron Emission Tomography scan in differentiating enhancing brain tumors. Indian J Nucl Med (2011) 0.75
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells. Sci Rep (2015) 0.75
Positron emission tomography (PET) in the evaluation of patients with cancer. Trans Am Clin Climatol Assoc (1999) 0.75
Mitochondria in relation to cancer metastasis: introduction to a mini-review series. J Bioenerg Biomembr (2012) 0.75
Simultaneous in vivo fluorescent markers for perfusion, protoporphyrin metabolism and EGFR expression for optically guided identification of orthotopic glioma. Clin Cancer Res (2016) 0.75
CT, MRI, and PET in a case of intractable epilepsy. Childs Nerv Syst (1996) 0.75
Positron emission tomography and the central nervous system. Arch Dis Child (1999) 0.75
Usefulness of positron emission tomographic studies for gliomas. Neurol Med Chir (Tokyo) (2016) 0.75
[18F] FDG uptake: pay attention to candies. Ecancermedicalscience (2007) 0.75
Sexual dimorphism in glioma glycolysis underlies sex differences in survival. JCI Insight (2017) 0.75
[Molecular imaging in neurological diseases]. Radiologe (2016) 0.75
MicroRNA regulation and analytical methods in cancer cell metabolism. Cell Mol Life Sci (2017) 0.75
[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression. PLoS One (2017) 0.75
The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem (1977) 11.55
Diffusion tensor MR imaging of the human brain. Radiology (1996) 9.84
Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am (1990) 8.22
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab (1990) 6.62
Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol (1979) 5.83
Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA (1999) 5.61
The epidemiology of chronic pain in the community. Lancet (1999) 5.39
Impaired odour discrimination on desynchronization of odour-encoding neural assemblies. Nature (1997) 4.15
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse (1993) 4.13
Hemangiopericytoma. An analysis of 106 cases. Hum Pathol (1976) 4.03
Pathophysiology of syringomyelia associated with Chiari I malformation of the cerebellar tonsils. Implications for diagnosis and treatment. J Neurosurg (1994) 3.91
Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease. N Engl J Med (1977) 2.94
Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med (1967) 2.92
Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry (1991) 2.89
Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev (2006) 2.82
Comparison and evaluation of retrospective intermodality brain image registration techniques. J Comput Assist Tomogr (1997) 2.76
Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science (1990) 2.74
Inhibition of monoamine oxidase B in the brains of smokers. Nature (1996) 2.62
Evolution of cortical activation during recovery from corticospinal tract infarction. Stroke (2000) 2.56
Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience (2007) 2.55
Changes in D(--)-beta-hydroxybutyric dehydrogenase activity during brain maturation in the rat. J Biol Chem (1967) 2.55
Magnetic resonance imaging of stationary blood: a review. Med Phys (1988) 2.54
Non-traumatic cerebrospinal fluid rhinorrhoea. J Neurol Neurosurg Psychiatry (1968) 2.42
The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res (1979) 2.41
von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology (1995) 2.38
Measurement of local cerebral blood flow with iodo [14C] antipyrine. Am J Physiol (1978) 2.34
The arthritis of familial Mediterranean fever (FMF). Arthritis Rheum (1966) 2.32
Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med (1988) 2.32
Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science (1979) 2.22
Disk fragment migration. Radiology (1990) 2.22
Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology (1983) 2.20
Long-term frontal brain metabolic changes in cocaine abusers. Synapse (1992) 2.16
Relation between physiological function and energy metabolism in the central nervous system. J Neurochem (1977) 2.08
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med (1978) 2.07
Feasibility of a visual prosthesis for the blind based on intracortical microstimulation of the visual cortex. Brain (1996) 2.06
Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. Fed Proc (1981) 2.05
A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med (1980) 2.01
Spinal arteriovenous malformations: a comparison of dural arteriovenous fistulas and intradural AVM's in 81 patients. J Neurosurg (1987) 1.92
New approaches to robotics. Science (1991) 1.87
Is [1-11C]putrescine useful as a brain tumor marker? J Nucl Med (1992) 1.80
The course of chronic pain in the community: results of a 4-year follow-up study. Pain (2002) 1.79
Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A (1996) 1.78
Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr (1984) 1.75
Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J Neurochem (1980) 1.73
Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose. J Cereb Blood Flow Metab (1981) 1.71
Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med (1994) 1.70
Metabolic mapping of the primary visual system of the monkey by means of the autoradiographic [14C]deoxyglucose technique. Proc Natl Acad Sci U S A (1976) 1.68
Local cerebral blood flow during hibernation, a model of natural tolerance to "cerebral ischemia". J Cereb Blood Flow Metab (1994) 1.67
Effects of anesthesia on functional activation of cerebral blood flow and metabolism. Proc Natl Acad Sci U S A (2001) 1.67
Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry (1990) 1.66
Beam hardening in x-ray reconstructive tomography. Phys Med Biol (1976) 1.65
Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA (1997) 1.63
The neurogenetics of mucolipidosis type IV. Neurology (2002) 1.62
Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med (1978) 1.60
Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. Proc Natl Acad Sci U S A (1985) 1.59
Cortical abnormalities in Alzheimer's disease. Ann Neurol (1984) 1.57
Changes in chronic pain severity over time: the Chronic Pain Grade as a valid measure. Pain (2000) 1.54
Intersubject variability of brain glucose metabolic measurements in young normal males. J Nucl Med (1994) 1.54
T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology (1999) 1.52
Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. J Virol (1992) 1.52
Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. Radiology (1990) 1.51
The diagnosis of acute acalculous cholecystitis: a comparison of sonography, scintigraphy, and CT. AJR Am J Roentgenol (1986) 1.50
Cerebral oxygen/glucose ratio is low during sensory stimulation and rises above normal during recovery: excess glucose consumption during stimulation is not accounted for by lactate efflux from or accumulation in brain tissue. J Cereb Blood Flow Metab (1999) 1.50
Synovial giant cells in rheumatoid arthritis. Am J Pathol (1966) 1.49
Local cerebral glucose utilization in controlled graded levels of hyperglycemia in the conscious rat. J Cereb Blood Flow Metab (1988) 1.49
Patterns of molar wear in hunger-gatherers and agriculturalists. Am J Phys Anthropol (1984) 1.49
Edema associated with calcified lesions in neurocysticercosis. Neurology (1999) 1.48
Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET study. Eur Arch Psychiatry Clin Neurosci (1994) 1.48
Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn Reson Med (1997) 1.46
Meningiomas in lymphangioleiomyomatosis. JAMA (2001) 1.46
The occurrence of bone and cartilage in mammary tumors. Am J Clin Pathol (1969) 1.45
Estimation of left ventricular mass and infarct size from nitrogen-13-ammonia PET images based on pathological examination of explanted human hearts. J Nucl Med (1993) 1.44
Neuroimaging of juvenile pilocytic astrocytomas: an enigma. Radiology (1993) 1.44
Allometric scaling in the dentition of primates and prediction of body weight from tooth size in fossils. Am J Phys Anthropol (1982) 1.44
A pituitary growth-promoting factor for articular chondrocytes in monolayer culture. Endocrinology (1972) 1.43
Multiple system atrophy (Shy-Drager syndrome): MR imaging. Radiology (1986) 1.43
Pregnancy pancreatitis. Am J Gastroenterol (1971) 1.42
Mapping of functional neural pathways by autoradiographic survey of local metabolic rate with (14C)deoxyglucose. Science (1975) 1.42
In vitro osteoblast response to ferritic stainless steel fiber networks for magneto-active layers on implants. J Biomed Mater Res A (2012) 1.42
Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology (1995) 1.42
Ovarian hyperstimulation: actual and theoretical risks. BMJ (1991) 1.41
Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol (1988) 1.41
Microradiographic study of the calcified layer of articular cartilage. Arch Pathol (1970) 1.41
Soft tissue tumors of the penis. A clinicopathologic study of 46 cases. Cancer (1970) 1.41
Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients. Biol Psychiatry (1988) 1.40
Radiometric estimation of the replication time of bacteria in culture: an objective and precise approach to quantitative microbiology. J Nucl Med (1978) 1.40
Sensitivity, specificity and predictive accuracy of radionuclide cineangiography during exercise in patients with coronary artery disease. Comparison with exercise electrocardiography. Circulation (1979) 1.40
Driving whilst plastered: is it safe, is it legal? A survey of advice to patients given by orthopaedic surgeons, insurance companies and the police. Injury (2004) 1.39
Osteoarthritis as a remodeling process. J Rheumatol (1987) 1.37
Chronic pain and the use of conventional and alternative therapy. Fam Pract (2003) 1.37
Computerized densitometry and color coding of [14C] deoxyglucose autoradiographs. Ann Neurol (1980) 1.37
Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Exp Clin Psychopharmacol (2001) 1.37
A quantitative theory of the Hounsfield unit and its application to dual energy scanning. J Comput Assist Tomogr (1977) 1.36